REPORT ID 1564

EMEA (Europe, Middle East and Africa) Heparin Sodium Market Report 2017

Publish Date
06-Dec-17
Pages
113
Format
Electronic (PDF)

In this report, the EMEA Heparin Sodium market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Heparin Sodium for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Heparin Sodium market competition by top manufacturers/players, with Heparin Sodium sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Shenzhen Hepalink
    Bioib?rica
    Nanjing King-friend
    Pfizer
    SPL
    Dongcheng Biochemicals
    Changzhou Qianhong Bio-pharma
    Changshan Biochemical
    Pharma Action
    Baxter
    Dongying Tiandong Pharmaceutical
    Opocrin
    Aspen Oss
    Xinbai Pharmaceuticals
    Yino Pharma Limited
    Sichuan Deebio

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Oral Type
    Injection Type

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Treatment of Venous Thromboembolism
    Complications of Pregnancy
    Cardioversion of Atrial Fibrillation/Flutter

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Heparin Sodium Market Report 2017
1 Heparin Sodium Overview
    1.1 Product Overview and Scope of Heparin Sodium
    1.2 Classification of Heparin Sodium
        1.2.1 EMEA Heparin Sodium Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Heparin Sodium Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Oral Type
        1.2.4 Injection Type
    1.3 EMEA Heparin Sodium Market by Application/End Users
        1.3.1 EMEA Heparin Sodium Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Treatment of Venous Thromboembolism
        1.3.3 Complications of Pregnancy
        1.3.4 Cardioversion of Atrial Fibrillation/Flutter
    1.4 EMEA Heparin Sodium Market by Region
        1.4.1 EMEA Heparin Sodium Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Heparin Sodium (2012-2022)
        1.5.1 EMEA Heparin Sodium Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Heparin Sodium Revenue and Growth Rate (2012-2022)

2 EMEA Heparin Sodium Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Heparin Sodium Market Competition by Players/Manufacturers
        2.1.1 EMEA Heparin Sodium Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Heparin Sodium Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Heparin Sodium Sale Price by Players (2012-2017)
    2.2 EMEA Heparin Sodium (Volume and Value) by Type/Product Category
        2.2.1 EMEA Heparin Sodium Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Heparin Sodium Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Heparin Sodium Sale Price by Type (2012-2017)
    2.3 EMEA Heparin Sodium (Volume) by Application
    2.4 EMEA Heparin Sodium (Volume and Value) by Region
        2.4.1 EMEA Heparin Sodium Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Heparin Sodium Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Heparin Sodium Sales Price by Region (2012-2017)

3 Europe Heparin Sodium (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Heparin Sodium Sales and Value (2012-2017)
        3.1.1 Europe Heparin Sodium Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Heparin Sodium Revenue and Growth Rate (2012-2017)
    3.2 Europe Heparin Sodium Sales and Market Share by Type
    3.3 Europe Heparin Sodium Sales and Market Share by Application
    3.4 Europe Heparin Sodium Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Heparin Sodium Sales Volume by Countries (2012-2017)
        3.4.2 Europe Heparin Sodium Revenue by Countries (2012-2017)
        3.4.3 Germany Heparin Sodium Sales and Growth Rate (2012-2017)
        3.4.4 France Heparin Sodium Sales and Growth Rate (2012-2017)
        3.4.5 UK Heparin Sodium Sales and Growth Rate (2012-2017)
        3.4.6 Russia Heparin Sodium Sales and Growth Rate (2012-2017)
        3.4.7 Italy Heparin Sodium Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Heparin Sodium Sales and Growth Rate (2012-2017)

4 Middle East Heparin Sodium (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Heparin Sodium Sales and Value (2012-2017)
        4.1.1 Middle East Heparin Sodium Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Heparin Sodium Revenue and Growth Rate (2012-2017)
    4.2 Middle East Heparin Sodium Sales and Market Share by Type
    4.3 Middle East Heparin Sodium Sales and Market Share by Application
    4.4 Middle East Heparin Sodium Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Heparin Sodium Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Heparin Sodium Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Heparin Sodium Sales and Growth Rate (2012-2017)
        4.4.4 Israel Heparin Sodium Sales and Growth Rate (2012-2017)
        4.4.5 UAE Heparin Sodium Sales and Growth Rate (2012-2017)
        4.4.6 Iran Heparin Sodium Sales and Growth Rate (2012-2017)

5 Africa Heparin Sodium (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Heparin Sodium Sales and Value (2012-2017)
        5.1.1 Africa Heparin Sodium Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Heparin Sodium Revenue and Growth Rate (2012-2017)
    5.2 Africa Heparin Sodium Sales and Market Share by Type
    5.3 Africa Heparin Sodium Sales and Market Share by Application
    5.4 Africa Heparin Sodium Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Heparin Sodium Sales Volume by Countries (2012-2017)
        5.4.2 Africa Heparin Sodium Revenue by Countries (2012-2017)
        5.4.3 South Africa Heparin Sodium Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Heparin Sodium Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Heparin Sodium Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Heparin Sodium Sales and Growth Rate (2012-2017)

6 EMEA Heparin Sodium Manufacturers/Players Profiles and Sales Data
    6.1 Shenzhen Hepalink
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Heparin Sodium Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Shenzhen Hepalink Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bioib?rica
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Heparin Sodium Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bioib?rica Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Nanjing King-friend
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Heparin Sodium Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Nanjing King-friend Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Heparin Sodium Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 SPL
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Heparin Sodium Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 SPL Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Dongcheng Biochemicals
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Heparin Sodium Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Dongcheng Biochemicals Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Changzhou Qianhong Bio-pharma
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Heparin Sodium Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Changshan Biochemical
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Heparin Sodium Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Changshan Biochemical Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Pharma Action
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Heparin Sodium Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Pharma Action Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Baxter
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Heparin Sodium Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Baxter Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Dongying Tiandong Pharmaceutical
    6.12 Opocrin
    6.13 Aspen Oss
    6.14 Xinbai Pharmaceuticals
    6.15 Yino Pharma Limited
    6.16 Sichuan Deebio

7 Heparin Sodium Manufacturing Cost Analysis
    7.1 Heparin Sodium Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Heparin Sodium

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Heparin Sodium Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Heparin Sodium Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Heparin Sodium Market Forecast (2017-2022)
    11.1 EMEA Heparin Sodium Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Heparin Sodium Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Heparin Sodium Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Heparin Sodium Price and Trend Forecast (2017-2022)
    11.2 EMEA Heparin Sodium Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Heparin Sodium Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Heparin Sodium Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Heparin Sodium Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Heparin Sodium Sales Forecast by Type (2017-2022)
    11.7 EMEA Heparin Sodium Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer